| Accession Number | 0001610717-26-000085 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Clinical Development | Common Stock | โ | Mar 1, 2026 | Grant/Award | 15,100 | $0.00 | $0.00 | 118,073 | Direct | โ | View Details | |
EVP, Clinical Development | Stock Option (Right to Buy) | Derivative | Mar 1, 2026 | Grant/Award | 34,000 | $0.00 | $0.00 | 34,000 | Direct | โ | View Details |